IP Library Granted Patent US 11,643,636
Granted Patent B2
US 11,643,636 · App. 16/507,586 · Granted May 9, 2023

Method of creating human pluripotent stem cell derived brain pericyte-like cells

Inventors: Eric V. Shusta (Madison, WI); Sean P. Palecek (Verona, WI); Matthew Stebbins (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C12N5/0618C12N2506/02C12N2506/45
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,643,636
App. No.
16/507,586
Granted
May 9, 2023
Kind
B2
Abstract

A population of brain pericyte-like cells, wherein the cells express pericyte markers but do not express ACTA2 and wherein the cells are generated from hPSCs, is disclosed herein.

Claims (8)

1. A method of creating a population of brain pericyte-like cells, wherein the cells express pericyte markers but do not express α-smooth muscle actin (α-SMA)and wherein the cells are generated from human pluripotent stem cells (hPSC), comprising the steps of

a. culturing hPSC in culture medium supplemented with CHIR99021, SB431542, fibroblast growth factor 2, and dorsomorphin for about 15 days to produce p75-nerve growth factor receptor (NGFR)+ human natural killer-1 (HNK-1)+ neural crest stem cells (NCSCs),

b. sorting p75-NGFR + cells and re-plating the p75-NGFR + cells to produce an enriched population of p75-NGFR + NCSCs,

c. culturing the cells of step (b) in medium with an addition of serum for about 11 days, and

d. isolating cells that express pericyte markers calponin 1 (CNN1), neuron-glial antigen 2 (NG2), and platelet-derived growth factor receptor beta (PDGFRB) but do not express α-SMA to produce population of brain pericyte-like cells.

2. The method of claim 1 , wherein the NCSCs of step (b) are p75-NGFR + HNK-1 + AP-2 + NCCs.

3. The method of claim 1 , wherein the population of cells express one or more transcripts of pericyte markers selected from the group consisting of chondroitin sulfate proteoglycan 4 (CSPG4), PDGFRB, CNN1, transgelin (TAGLN), alanyl aminopeptidase (ANPEP), T-box transcription factor 18 (TBX18), ATP binding cassette subfamily C member 9 (ABCC9) and potassium inwardly rectifying channel subfamily J member 8 (KCNJ8).

4. The method of claims 1 , wherein the method produces the brain pericyte-like cell population that is at least 90% NG2 + PDGFRB + .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2024
From: PALECEK, SEAN; SHUSTA, ERIC; STEBBINS, MATTHEW
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 067438/0276 →
CONFIRMATORY LICENSE Recorded Aug 15, 2019
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: DEFENSE THREAT REDUCTION AGENCY, US DOD
Reel/Frame 050062/0832 →
Continuity (2)
Provisional Application 62696230 · Jul 10, 2018
Related Publication 20200017827A1 · Jan 16, 2020